Zhejiang Hisun Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ZHEJIANG HISUN PHARM
ZHEJIANG HISUN PHARM has two approved drugs.
Drugs and US Patents for Zhejiang Hisun Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zhejiang Hisun Pharm | MYCOPHENOLATE MOFETIL | mycophenolate mofetil | TABLET;ORAL | 204076-001 | Nov 16, 2017 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Zhejiang Hisun Pharm | MYCOPHENOLATE MOFETIL | mycophenolate mofetil | CAPSULE;ORAL | 204077-001 | Nov 13, 2017 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

